PropertyValue
?:abstract
  • Cancer patients are vulnerable to COVID-19 with consequences on treatment delays and on mortality rate. This Comment explores the interaction between COVID-19 and cancer with attention paid to the modulation by cancer treatments of both ADAM17 and TMPRSS2, the proteases which control ACE2 processing, the SARS-CoV-2 target.
?:creator
?:doi
  • 10.1038/s41416-020-01246-0
?:doi
?:journal
  • British_journal_of_cancer
?:license
  • unk
?:pmid
?:pmid
  • 33531686.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • More light on cancer and COVID-19 reciprocal interaction.
?:type
?:year
  • 2021-02-03

Metadata

Anon_0  
expand all